| dronabinol oral / Generic mfg. |
| Recruiting | 2a | 20 | RoW | SCI -110, Dronabinol and PEA | The Israeli Medical Center for Alzheimer's | Alzheimer Disease | 06/23 | 06/23 | | |
NCT00123201: Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine Headache |
|
|
| Completed | 2 | | US | Dronabinol MDI | Solvay Pharmaceuticals, Nektar Therapeutics | Migraine With Aura, Migraine Without Aura | 03/07 | 03/07 | | |
NCT00418925: Efficacy of Dronabinol for the Treatment of Cervical Dystonia |
|
|
| Unknown status | 2 | 38 | Canada | Dronabinol, Marinol(R) | University Health Network, Toronto, Dystonia Medical Research Foundation | Cervical Dystonia | 11/09 | 12/09 | | |
| Completed | 2 | 156 | US | Dronabinol, Marinol, Placebo | New York State Psychiatric Institute, National Institute on Drug Abuse (NIDA) | Marijuana Abuse | 12/09 | 12/09 | | |
| Completed | 2 | 22 | Europe | Delta-THC, Namisol, Cannabis, ECP002A, placebo, Placebo Namisol | Radboud University Medical Center, European Union | Dementia | 12/13 | 12/13 | | |
| Completed | 2 | 50 | Europe | delta-9-tetrahydrocannabinol (delta-THC), Namisol, Cannabis, ECP002A, Placebo, Acetaminophen, Paracetamol | Radboud University Medical Center, Health Valley, Netherlands | Behavioural Disturbances, Pain, Dementia, Alzheimer's Dementia, Vascular Dementia | 06/14 | 06/14 | | |
2007-004247-30: The Role of the Endocannabinoid System in Psychiatric Disorders and Symptoms: a Pharmacological fMRI study |
|
|
| | 2 | 120 | Europe | Dronabinol, | University Medical Center Utrecht | THis research project will be performed with patients with a psychiatric disorder in order to determine whether the endocannabinoid system is altered in psychiatric diseases. Psychistric disorders that are investigated are schizophrenia, depression, ADHD, OCD and addiction. Patients will be compared with healthy controls. | | | | |
2010-022033-28: A study investigating safety, tolerability and efficacy of ECP002A (Δ9-THC) in Multiple Sclerosis patients suffering from spasticity and pain. |
|
|
| Completed | 2 | 24 | Europe | Namisol, ECP002A, | Echo Pharmaceuticals B.V., Echo Pharmaceuticals B.V. | Multiple Sclerosis | | | | |
2017-004823-66: Early-life stress, the endocannabinoid system, and fear memory extinction |
|
|
| Ongoing | 2 | 48 | Europe | Namisol, Hydrocortison CF, ECP002A, RVG 50730, Tablet, Hydrocortison CF | Radboudumc, Radboudumc | healthy volunteers gezonde vrijwilligers, intended indication: posttraumatic stress disorder (PTSD) beoogde indicatie: posttraumatic stress disorder (PTSD), Psychiatry and Psychology [F] - Mental Disorders [F03] | | | | |
2018-000014-38: A Phase IIa Study to Determine the Safety, Tolerability and Efficacy of a daily oral dose of THX-110 in Adult Patients with Tourette Syndrome (TS) |
|
|
| Not yet recruiting | 2 | 60 | Europe | THX-110 [Dronabinol], THX-110 [PEA (Palmitoylethanolamide)], Capsule, soft, Tablet, Dronabinol Capsules, USP | Therapix Biosciences Ltd., Therapix Biosciences Ltd. | Tourette Syndrome, Neuropsychiatric disorder characterized by multiple motor or vocal tics., Diseases [C] - Nervous System Diseases [C10] | | | | |
| Completed | 2 | 75 | US | Dronabinol (Marinol®), Placebo | Johns Hopkins University, Mclean Hospital, Miami Jewish Health, National Institute on Aging (NIA), Tufts Medical Center | Alzheimer's Disease | 05/24 | 05/24 | | |
NCT05612711: Dronabinol for Agitation in Dementia Crossover Trial |
|
|
| Not yet recruiting | 2 | 50 | US | Dronabinol, Marinol | Ralph H. Johnson VA Medical Center, JHSPH Center for Clinical Trials | Dementia Moderate, Dementia Severe, Agitation,Psychomotor, Behavioral Symptoms | 11/25 | 11/26 | | |
NCT05269628: Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype |
|
|
| Recruiting | 2 | 166 | US | Cannabidiol (CBD), Epidiolex®, Tetrahydrocannabinol (THC), Marinol®, dronabinol, Placebo CBD, Placebo THC | Tiffany J. Braley, MD, MS, National Center for Complementary and Integrative Health (NCCIH) | Multiple Sclerosis, Sleep, Pain | 06/26 | 06/26 | | |
NCT01832766: The Effects of Cannabis Use in People With Schizophrenia on Clinical, Neuropsychological and Physiological Phenotypes |
|
|
| Terminated | 1/2 | 13 | US | Dronabinol, Marinol, Placebo Comparator, Sugar Pill | University of Colorado, Denver, National Alliance for Research on Schizophrenia and Depression | Schizophrenia | 05/10 | 05/11 | | |
| Terminated | 1/2 | 41 | US | Inhaled Cannabis, Cannabis, Oral THC, dronabinol, Oral Placebo, placebo, Inhaled placebo | University of California, Davis, National Multiple Sclerosis Society | Multiple Sclerosis | 08/11 | 08/11 | | |
